These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6262889)

  • 1. The new histamine H2-receptor antagonist ranitidine. Duration of action.
    Dammann HG; Müller P; Kather H; Simon B
    Res Exp Med (Berl); 1981; 178(2):151-4. PubMed ID: 6262889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The new histamine H2-receptor antagonist ranitidine. Duration of action.
    Dammann HG; Simon B
    Scand J Gastroenterol Suppl; 1981 Jun; 69():39-43. PubMed ID: 6119781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of ranitidine, a new histamine H2-receptor antagonist, on secretagogue-stimulated gastric secretion in Heidenhain pouch dogs (author's transl)].
    Ohtsuki H; Okabe S
    Nihon Yakurigaku Zasshi; 1981 Dec; 78(6):539-47. PubMed ID: 6120885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study with ranitidine and cimetidine on gastric secretion in normal volunteers.
    Sewing KF; Billian A; Malchow H
    Gut; 1980 Sep; 21(9):750-2. PubMed ID: 6107265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ranitidine on gastric acid secretory response curves to histamine, pentagastrin or bethanechol in the dog with a Heidenhain pouch.
    Daly MJ; Humphray JM; Bunce KT; Stables R
    Agents Actions; 1981 Apr; 11(1-2):160-4. PubMed ID: 6113743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of gastric acid secretion by intravenous amino acid infusion and its inhibition by H2-receptor antagonists ranitidine and cimetidine.
    Weingart J; Kunert H; Ottenjann R
    Scand J Gastroenterol Suppl; 1981 Jun; 69():61-5. PubMed ID: 6119784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of gastric acid inhibition by ranitidine in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Digestion; 1981; 22(3):119-25. PubMed ID: 6116636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of JB-9315, a new selective histamine H2-receptor antagonist.
    Palacios B; Montero MJ; Sevilla MA; San Román L
    Gen Pharmacol; 1998 Feb; 30(2):181-9. PubMed ID: 9502172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenteral ranitidine: onset and duration of action.
    Dammann HG; Müller P; Simon B
    Br J Anaesth; 1982 Nov; 54(11):1235-6. PubMed ID: 6128015
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between ranitidine plasma levels and reduction of postprandial intragastric acidity in healthy man.
    Berstad A; Frislid K; Rydning A
    Scand J Gastroenterol; 1982 Jan; 17(1):109-12. PubMed ID: 6127787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of gastric secretion in man with a new H2-receptor antagonist, ranitidine.
    Kett K; Aadland E; Berstad A
    Scand J Gastroenterol; 1980; 15(2):249-51. PubMed ID: 6104355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranitidine--a new H2-receptor antagonist.
    Woodings EP; Dixon GT; Harrison C; Carey P; Richards DA
    Gut; 1980 Mar; 21(3):187-91. PubMed ID: 6105117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects of a new histamine H2 receptor agonist (impromidine) and antagonist (ranitidine).
    Pollock DM; Banks RO; Jacobson ED
    Pharmacol Res Commun; 1982 Jul; 14(7):605-12. PubMed ID: 6127724
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of pentagastrin-stimulated and nocturnal gastric secretion by ranitidine. A new H2-receptor antagonist.
    Peden NR; Saunders JH; Wormsley KG
    Lancet; 1979 Mar; 1(8118):690-2. PubMed ID: 85934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Furan H2-antagonist ranitidine inhibits pentagastrin-stimulated gastric secretion stronger than cimetidine.
    Domschke W; Lux G; Domschke S
    Gastroenterology; 1980 Dec; 79(6):1267-71. PubMed ID: 6108279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    Cavanagh RL; Usakewicz JJ; Buyniski JP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies on acid inhibition by ranitidine given simultaneously with pentagastrin].
    Simon B; Bergdolt H; Dammann HG; Müller P
    Arzneimittelforschung; 1992 Feb; 42(2):133-5. PubMed ID: 1610422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of ranitidine, a new histamine H2-receptor antagonist, on secretagogue-stimulated gastric secretion in rats: comparison with cimetidine (author's transl)].
    Okabe S; Kawakami M
    Nihon Yakurigaku Zasshi; 1981 Aug; 78(2):57-62. PubMed ID: 6119281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the histamine-stimulated gastric secretion in healthy subjects by the H2-receptor antagonist ranitidine.
    Bohman T; Myren J; Larsen S
    Scand J Gastroenterol; 1980; 15(2):183-9. PubMed ID: 6104354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.